coronavirus September 22, 2021 11:13 pm

FDA Authorizes Pfizer COVID-19 Boosters for High-Risk, Seniors

The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the FDA signed off on the targeted use of extra shots. Ian Cull reports

US & World Videos

2:19

San Francisco barbershop struggles to stay open after pandemic
0:51

Alameda County using dogs to detect COVID
3:57

Interview: Doctor's perspective on COVID 4 years after shutdown started
2:27

Marking 4 years since COVID-19 shut down the Bay Area
2:09

CDC updates COVID isolation guidelines
Exit mobile version